i&i Bio is a Luxembourg-based venture capital firm that invests in innovative European Life Sciences companies focused on drug discoveries, medical devices, diagnostics and digital health. With over €53M under management, i&i Bio plans to invest in about 20 early-stage companies. i&i Bio is led by an experienced team of professionals with backgrounds in private equity, the healthcare industry and venture capital who support entrepreneurs on their journey to global success. Thanks to close cooperation with the fund’s main sponsor, the biotech academic incubator, i&i Prague, i&i Bio has a great opportunity to be at the inception of transformative Central European technologies.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 6, Rue Adolphe, Canton Of Vieux-Habitants,luxembourg 1116,luxembourg
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.inibio.eu
- Keywords
- biotech, drug discoveries, medical devices, diagnostics, digital health, investment, Life Sciences, early-stage, seed, series A, series B.
- HQ
- Canton of Vieux-Habitants, Luxembourg
I&i Biotech Fund Questions
I&I Biotech Fund's website is http://www.inibio.eu
I&I Biotech Fund's LinkedIn profile is https://lu.linkedin.com/company/i-i-biotech-fund
I&I Biotech Fund has
8 employees.
View email and phone details for 8
employees at I&I Biotech Fund.
I&I Biotech Fund's industry is
Venture Capital and Private Equity Principals
I&I Biotech Fund's top competitors are
Qbic Fund | Venture Capital,
Tensor Ventures,
I&i Prague,
Pace Ventures,
Prague.bio,
Vives Partners,
Kadmos Capital Ltd,
Future Planet Capital,
Innospark Ventures,
Antiverse.
I&I Biotech Fund's categories are Venture Capital and Private Equity Principals
I&I Biotech Fund's founding year is 2021
